Cost–Effectiveness Analysis of Dapagliflozin Plus Standard Treatment for Patients With Type 2 Diabetes and High Risk of Cardiovascular Disease in China

PURPOSE: To evaluate the long-term cost-effectiveness of dapagliflozin, in addition to standard treatment, for the treatment of adult patients with type 2 diabetes (T2DM) at high cardiovascular risk from the Chinese healthcare system perspective. METHODS: A decision-analytic Markov model with one-ye...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Kaiyu, Wang, Yao, Sun, Sijia, Zhu, Qian, Zhou, Weifeng, Liu, Jiatao, Zhu, Dongchun, Xie, Xuefeng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Public Health
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9326075/
https://www.ncbi.nlm.nih.gov/pubmed/35910934
http://dx.doi.org/10.3389/fpubh.2022.936703

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9326075/
https://www.ncbi.nlm.nih.gov/pubmed/35910934
http://dx.doi.org/10.3389/fpubh.2022.936703

Ejemplares similares